About a month ago, we received an inquiry from a government contractor asking if our company, Yukon Ventures, would be interested in a top-secret cold storage opportunity. We read between the lines and understood that the contractor was talking about the rollout of the new COVID-19 vaccine, a subject dominating headlines everywhere.
The mysterious contractor could not outline a specific RFP he was responding to, nor could he plainly outline what exactly the opportunity might be. Without really understanding what environment vaccines might require in the long run, he was phishing for opportunities in what he surmised could be a lucrative contract with the GSA. For a moment, with stars in our eyes, we imagined being a part of this historic process. Should we be building vaccine storage into our new facilities? Moreover, should we build facilities specific to vaccine distribution? Would pharmaceuticals be the bright, shiny future of cold storage?